Rick Jonathan W, De Devea R, Shih Terri, Alavi Afsaneh, Kirby Joslyn S, Naik Haley B, Frew John W, Sayed Christopher J, Hsiao Jennifer L, Shi Vivian Y
Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
Skin Appendage Disord. 2022 Jul;8(4):287-290. doi: 10.1159/000521268. Epub 2022 Jan 10.
Hidradenitis suppurativa (HS) patients may be at increased risk of COVID-19 infection and complications from their medications and comorbidities. There is a lack of expert consensus on recommendations for the COVID-19 vaccine for HS patients. Herein, we aim to provide expert-driven consensus recommendations regarding COVID-19 vaccinations in HS patients.
A modified Delphi consensus survey developed by a core committee of 7 dermatologist HS experts consisting of 4 demographic questions and 12 practice statements was distributed to the US HS Foundation-sponsored provider listserv. Participants were attending physician HS experts. Survey results were to be reviewed by the core group and revised and resubmitted until consensus (≥70% agreement) was achieved.
Among the 33 survey participants, there were 30 (87%) dermatologists, 1 general surgeon, 1 plastic surgeon, and 1 rheumatologist. Consensus for all 12 statements on vaccine counseling and HS treatment counseling was achieved after the first round.
DISCUSSION/CONCLUSION: For now, this consensus can serve as a resource for clinicians discussing COVID-19 vaccination with their HS patients. These recommendations will need to be updated as new evidence on COVID-19 emerges.
化脓性汗腺炎（HS）患者感染新冠病毒以及因药物和合并症出现并发症的风险可能更高。对于HS患者接种新冠疫苗的建议，目前缺乏专家共识。在此，我们旨在提供由专家主导的关于HS患者接种新冠疫苗的共识性建议。
由7名皮肤科HS专家组成的核心委员会制定了一项经过修改的德尔菲共识调查，其中包括4个人口统计学问题和12条实践声明，并分发给美国HS基金会赞助的医疗服务提供者邮件列表。参与者均为HS专科主治医生专家。调查结果将由核心小组进行审查，然后进行修订并重新提交，直至达成共识（≥70%的同意率）。
在33名参与调查者中，有30名（87%）皮肤科医生、1名普通外科医生、1名整形外科医生和1名风湿病学家。第一轮调查后，关于疫苗咨询和HS治疗咨询的所有12条声明均达成了共识。
讨论/结论：目前，这一共识可作为临床医生与HS患者讨论新冠疫苗接种问题的参考资料。随着新冠病毒新证据的出现，这些建议需要更新。
